- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05117086
DASH Diet in Heart Failure Outpatients (DASH-HF)
January 30, 2024 updated by: University of California, Davis
DASH Diet in Heart Failure Pilot Study - Integration and Effectiveness of Medical Nutrition Therapy Counseling on DASH Diet in the Management of Heart Failure Patients in an Academic Outpatient Cardiology Clinic
The purpose of this study is to refine the classification of the effectiveness of the DASH diet for outpatient heart failure (HF) management, using behavioral, clinical, and laboratory correlative science approaches.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The overall objective of this pilot study is to refine the classification of the effectiveness of the DASH diet for outpatient HF management using behavioral, clinical, and laboratory correlative science approaches.
The investigators will integrate the use and evaluation of DASH diet nutrition education in a clinical population using a pragmatic study approach.
The investigators will assess dietary behavior change.
The investigators will assess the medical effectiveness of the DASH diet to improve patient symptomology and clinical biomarkers.
Exploratory investigations will involve metabolomics analyses of plasma samples for biomarker discovery of clinical phenotypes in HF patients, to characterize metabolic profiles related to dietary exposure.
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Francene Steinberg, PhD
- Phone Number: 530 752 0160
- Email: fmsteinberg@ucdavis.edu
Study Contact Backup
- Name: Brooke Wickman, MS
- Email: bewickman@ucdavis.edu
Study Locations
-
-
California
-
Sacramento, California, United States, 95817
- UC Davis Health Center - Cardiology Department
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Heart Failure diagnosis
- Guideline directed medical therapy optimization on stable regimen at least 30 days
Exclusion Criteria:
- BMI < 18/5 kg/m squared
- cardiac cachexia
- end-stage renal disease or dialysis
- acute inflammatory condition
- uncontrolled arrhythmias or ischemia
- status post heart transplant or implanted left ventricular assist device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dietary Intervention Arm
Subjects will receive the active intervention of nutrition education and medical nutrition therapy counseling for dietary and behavioral lifestyle changes.
The focus will be on DASH diet implementation and adherence for management of heart failure.
The subjects will have 4 study visits with a Registered Dietitian over 6 months (visits at 1, 2, 3, and 6 months).
Outcome measures will be assessed at baseline, 3 and 6 months.
|
Nutrition education and counseling on DASH diet, behavioral and lifestyle modifications
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dietary intake
Time Frame: Dietary intake at baseline
|
Dietary intake assessed by nutrient analysis of food records
|
Dietary intake at baseline
|
Dietary intake
Time Frame: Dietary intake at 3 months
|
Dietary intake assessed by nutrient analysis of food records
|
Dietary intake at 3 months
|
Dietary intake
Time Frame: Dietary intake at 6 months
|
Dietary intake assessed by nutrient analysis of food records
|
Dietary intake at 6 months
|
Diet score
Time Frame: Dietary intake at baseline
|
Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score).
Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.
|
Dietary intake at baseline
|
Diet score
Time Frame: Dietary intake at 3 months
|
Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score).
Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.
|
Dietary intake at 3 months
|
Diet score
Time Frame: Dietary intake at 6 months
|
Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score).
Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.
|
Dietary intake at 6 months
|
Blood Pressure
Time Frame: Systolic and diastolic Blood Pressure at baseline
|
Blood Pressure assessed with systolic and diastolic pressure
|
Systolic and diastolic Blood Pressure at baseline
|
Blood Pressure
Time Frame: Systolic and diastolic Blood Pressure at 3 months
|
Blood Pressure assessed with systolic and diastolic pressure
|
Systolic and diastolic Blood Pressure at 3 months
|
Blood Pressure
Time Frame: Systolic and diastolic Blood Pressure at 6 months
|
Blood Pressure assessed with systolic and diastolic pressure
|
Systolic and diastolic Blood Pressure at 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart Failure clinical marker
Time Frame: proBNP at baseline
|
proBNP will be assessed as a marker of severity of heart failure
|
proBNP at baseline
|
Heart Failure clinical marker
Time Frame: proBNP at 3 months
|
proBNP will be assessed as a marker of severity of heart failure
|
proBNP at 3 months
|
Heart Failure clinical marker
Time Frame: proBNP at 6 months
|
proBNP will be assessed as a marker of severity of heart failure
|
proBNP at 6 months
|
Patient report of HF symptoms
Time Frame: KCCQ at baseline
|
Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms.
Minimum to Maximum values: 0-100.
Higher scores represent better outcome.
|
KCCQ at baseline
|
Patient report of HF symptoms
Time Frame: KCCQ at 3 months
|
Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms.
Minimum to Maximum values: 0-100.
Higher scores represent better outcome.
|
KCCQ at 3 months
|
Patient report of HF symptoms
Time Frame: KCCQ at 6 months
|
Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms.
Minimum to Maximum values: 0-100.
Higher scores represent better outcome.
|
KCCQ at 6 months
|
Patient report of eating habit self efficacy
Time Frame: Eating Habits at Baseline
|
Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits.
Minimum to Maximum values:27-135.
Higher value is better outcome.
|
Eating Habits at Baseline
|
Patient report of eating habit self efficacy
Time Frame: Eating Habits at 3 months
|
Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits.
Minimum to Maximum values:27-135.
Higher value is better outcome.
|
Eating Habits at 3 months
|
Patient report of eating habit self efficacy
Time Frame: Eating Habits at 6 months
|
Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits.
Minimum to Maximum values:27-135.
Higher value is better outcome.
|
Eating Habits at 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Francene Steinberg, PhD, University of California, Davis
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2022
Primary Completion (Estimated)
February 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
November 1, 2021
First Submitted That Met QC Criteria
November 1, 2021
First Posted (Actual)
November 11, 2021
Study Record Updates
Last Update Posted (Estimated)
January 31, 2024
Last Update Submitted That Met QC Criteria
January 30, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1770356
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
US Department of Veterans AffairsCompleted
Clinical Trials on DASH diet
-
National Health Research Institutes, TaiwanTaipei Veterans General Hospital, TaiwanUnknown
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Case Western Reserve UniversityCompleted
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Assiut UniversityNot yet recruitingDyslipidemia Associated With Type II Diabetes Mellitus
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedHypertension | Diabetes | Insulin ResistanceUnited States
-
Duke UniversityCompletedHypertension | Chronic Kidney DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)Recruiting
-
Penn State UniversityNational Cattlemen's Beef AssociationCompletedCardiovascular Disease | Metabolic SyndromeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNot yet recruiting